title: HCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implications.
abstract: Hyperpolarization-activated cyclic nucleotide-gated channels (HCN) can act as pacemakers in the brain making them strong candidates for driving aberrant hypersynchronous network activity seen in epilepsy. Transcriptional changes in HCN channels occur in several animal models of epilepsy. However, only recently have genetic studies demonstrated sequence variation in HCN1 and HCN2 genes associated with human epilepsy. These include a triple proline deletion in HCN2 that increases channel function and occurs more often in patients with febrile seizure syndromes. Other HCNx gene variants have been described in idiopathic generalized epilepsy although the functional consequence of these remains unclear. In this review we explore potential cellular and network mechanisms involving HCN channels in the genetic epilepsies. We suggest how new genetic sequencing technology, medium-throughput functional assays and the ability to develop syndrome-specific animal models will provide a more comprehensive understanding of how I(h)  contributes to pathogenic mechanisms underlying human genetic epilepsy. We also discuss what is known about the pharmacological manipulation of HCN channels in the context of epilepsy and how this may help future efforts in developing HCN-channel-based therapy.
authors: Florey Neuroscience Institute and The Centre for Neuroscience, The University of Melbourne, Parkville, Victoria, Australia. careid@unimelb.edu.au
authors: Christopher A
authors: CA
authors: Reid
authors: A Marie
authors: AM
authors: Phillips
authors: Steven
authors: S
authors: Petrou
references: Prog Neurobiol. 2008 Nov;86(3):129-40
references: 18834920
references: Cereb Cortex. 2007 Mar;17(3):702-12
references: 16648453
references: Pharmacol Ther. 2010 Nov;128(2):274-80
references: 20705092
references: Neurobiol Dis. 2008 Oct;32(1):26-36
references: 18657617
references: Neuron. 2009 Jun 25;62(6):814-25
references: 19555650
references: J Clin Invest. 2010 Aug;120(8):2661-71
references: 20628201
references: Epilepsia. 2008 May;49(5):921-5
references: 18294204
references: Neurobiol Dis. 2009 Mar;33(3):499-508
references: 19150498
references: J Neurophysiol. 2009 Jan;101(1):129-40
references: 18971302
references: Epilepsia. 1990 Jul-Aug;31(4):391-6
references: 2369875
references: J Neurosci. 2007 Nov 21;27(47):13012-21
references: 18032674
references: J Neurosci. 2007 Sep 19;27(38):10128-42
references: 17881519
references: Ann Neurol. 2010 Apr;67(4):542-6
references: 20437590
references: J Neurosci. 2003 Jul 30;23(17):6826-36
references: 12890777
references: Nature. 1998 Jun 11;393(6685):587-91
references: 9634236
references: J Neurosci. 2007 May 30;27(22):5903-14
references: 17537961
references: Nat Neurosci. 2002 Aug;5(8):767-74
references: 12118259
references: Neurobiol Dis. 2008 Feb;29(2):297-305
references: 17964174
references: Neuron. 1998 Mar;20(3):553-63
references: 9539128
references: Eur J Neurosci. 2004 Jun;19(11):3048-58
references: 15182313
references: J Pharmacol Exp Ther. 2005 Nov;315(2):517-25
references: 16033909
references: Trends Neurosci. 2001 Jun;24(6):353-60
references: 11356508
references: J Biol Chem. 2001 Apr 20;276(16):13209-16
references: 11278749
references: Nat Med. 2001 Mar;7(3):331-7
references: 11231632
references: Ann Neurol. 2008 Sep;64(3):284-93
references: 18825662
references: J Neurosci. 2009 May 13;29(19):6250-65
references: 19439603
references: Front Cell Neurosci. 2008 Apr 17;2:2
references: 18946517
references: Ann N Y Acad Sci. 1999 Apr 30;868:741-64
references: 10414361
references: Front Neurosci. 2009 May 01;3(1):25-33
references: 19753094
references: Neuron. 2004 Oct 28;44(3):495-508
references: 15504329
references: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19152-7
references: 17146052
references: Nat Rev Neurosci. 2002 May;3(5):371-82
references: 11988776
references: J Neurophysiol. 2005 Dec;94(6):3872-83
references: 16093340
references: J Neurosci. 2005 Oct 26;25(43):9871-82
references: 16251434
references: J Neurosci. 2009 Jan 21;29(3):600-9
references: 19158287
references: J Biol Chem. 2009 Sep 18;284(38):25553-9
references: 19574228
references: J Neurosci. 2003 May 1;23(9):3658-68
references: 12736337
references: J Neurosci. 2002 Jun 1;22(11):4591-9
references: 12040066
references: J Neurosci. 2004 Nov 24;24(47):10750-62
references: 15564593
references: Br Med J (Clin Res Ed). 1985 May 4;290(6478):1307-10
references: 3922469
references: EMBO J. 2003 Jan 15;22(2):216-24
references: 12514127
references: Epilepsia. 2003 Feb;44(2):150-6
references: 12558567
references: J Neurosci. 2010 May 12;30(19):6678-88
references: 20463230
references: J Physiol. 2006 Aug 15;575(Pt 1):83-100
references: 16728450
references: J Physiol. 1999 Sep 1;519 Pt 2:505-14
references: 10457066
references: Trends Neurosci. 2007 Oct;30(10):490-6
references: 17897728
references: Neuropsychopharmacology. 2010 Jan;35(2):464-72
references: 19776733
references: Arch Neurol. 2009 Oct;66(10):1225-32
references: 19822777
references: Nat Neurosci. 1999 Jul;2(7):634-41
references: 10404196
references: Epilepsia. 2010 Apr;51(4):676-85
references: 20196795
references: Physiol Rev. 2009 Jul;89(3):847-85
references: 19584315
references: J Physiol. 2007 Jan 15;578(Pt 2):507-25
references: 17095562
references: J Physiol. 2007 Aug 15;583(Pt 1):37-56
references: 17569731
references: Neuron. 2009 Jun 25;62(6):802-13
references: 19555649
references: Genes Brain Behav. 2007 Oct;6(7):593-7
references: 17559416
references: Epilepsia. 2008 Oct;49(10):1686-95
references: 18397293
references: Neurobiol Dis. 2005 Jun-Jul;19(1-2):200-7
references: 15837575
references: Neurobiol Dis. 2008 Jan;29(1):59-70
references: 17931874
references: Exp Neurol. 2009 Sep;219(1):249-57
references: 19500574
references: Physiol Rev. 2008 Jul;88(3):919-82
references: 18626064
references: J Neurosci. 2009 Sep 2;29(35):10979-88
references: 19726656
references: Eur J Neurosci. 2006 Jun;23(12):3346-58
references: 16820024